Screening helps identify monogenic diabetes, study finds

Researchers have called for better screening to identify monogenic diabetes, following the development of a test which helped identify more cases of the condition. The study, which assessed 1,407 people in the United Kingdom with diabetes diagnosed at 30 years of age or younger, used C-peptide and islet autoantibodies€”highly sensitive and specific biomarkers for discriminating type 1 from non-type 1 diabetes€”in a biomarker screening pathway for monogenic diabetes. The use of the pathway resulted in the identification of 17 new cases of monogenic diabetes in addition to the 34 previously identified cases, indicating that the prevalence in patients diagnosed under